Approval · Notice of Compliance 18621 · 2016
TRUSOPT: Notice of Compliance 18621
Issued November 2, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18621
- Date
- November 2, 2016
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification numbers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRUSOPT | 02216205 | Cancelled Post Market |
| TRUSOPT (PRESERVATIVE-FREE FORMULATION) | 02269090 | Cancelled Post Market |
Medicinal ingredients
- DORZOLAMIDE HYDROCHLORIDE 20 MG per ML